COST EFFECTIVENESS OF AN OUTCOME BASED REIMBURSEMENT MODEL OF PCSK9 INHIBITORS

被引：1
|
作者：
Oren, Ohad
Oren, Michal
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Tel Aviv Univ, Tel Aviv, Israel
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(18)32294-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1753
引用
收藏
页码：1753 / 1753
页数：1
相关论文
共 50 条
  • [21] Access to PCSK9 Inhibitors
    Baum, Seth J.
    Lepor, Norman E.
    Robinson, Jennifer G.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2018, 19 : S47 - S50
  • [22] PCSK9 inhibitors are go
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (09) : 593 - 593
  • [23] Oral PCSK9 Inhibitors
    Anandita Agarwala
    Ramsha Asim
    Christie M. Ballantyne
    Current Atherosclerosis Reports, 2024, 26 : 147 - 152
  • [24] A SYSTEMATIC REVIEW OF COMPARATIVE EFFECTIVENESS OF EZETIMIBE AND PCSK9 INHIBITORS
    Park, T.
    Griggs, S.
    Henderson, E.
    Suh, D.
    Lee, S.
    VALUE IN HEALTH, 2017, 20 (09) : A614 - A614
  • [25] Oral PCSK9 Inhibitors
    Agarwala, Anandita
    Asim, Ramsha
    Ballantyne, Christie M.
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (05) : 147 - 152
  • [26] PCSK9 inhibitors are go
    Asher Mullard
    Nature Reviews Drug Discovery, 2015, 14 : 593 - 593
  • [27] PCSK9 Inhibitors and Managing Cost in the Managed Care Setting
    Stadler, Sheila L.
    Cook, Thomas J.
    AMERICAN JOURNAL OF MANAGED CARE, 2017, 23 (09): : S149 - S155
  • [28] Cost-effectiveness of PCSK9 Inhibitor Therapy In Reply
    Kazi, Dhruv S.
    Moran, Andrew E.
    Bibbins-Domingo, Kirsten
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (20): : 2152 - 2152
  • [29] PCSK9 Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues
    Zhuravleva, Marina, V
    Prokofievl, Alexey B.
    Shikh, Evgenia, V
    Serebrova, Svetlana Yu
    Gorodetskaya, Galina, I
    Demchenkova, Elena Yu
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2020, 16 (04) : 644 - 653
  • [30] Safety and Effectiveness of PCSK9 Inhibitors in Orthotopic Heart Transplant Patients
    Sammour, Yasser
    Austin, Bethany A.
    Borkon, Michael
    Everley, Mark P.
    Fendler, Timothy J.
    Khumri, Taiyeb M.
    Lawhorn, Stephanie L.
    Magalski, Anthony
    Nassif, Michael E.
    Vodnala, Deepthi
    Kao, Andrew C.
    Sperry, Brett W.
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S22 - S22
12345